Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of Hsp90 inhibitor STA-9090 (ganetespib) in relapsed or refractory small cell lung cancer has completed; results post…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Phase 2]
A Phase 2 trial evaluated zoledronic acid (Zometa) for bone metastases in lung cancer (including non-small cell and small cell) and was term…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Study of Arsenic Trioxide in Small Cell Lung Cancer [Phase 2]
Phase 2 trial of arsenic trioxide for small cell lung cancer has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing Topotecan + Cisplatin vs Etoposide + Cisplatin as first-line therapy for extensive-disease small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating combination chemotherapy with or without filgrastim in patients with previously untreated extensive-stage small c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of chemotherapy with exisulind in patients with extensive-stage small cell lung cancer has…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer [Phase 2]
Phase 2 trial comparing Topotecan plus apatinib versus Topotecan alone as second-line therapy for small-cell lung cancer is being studied. T…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid [Phase 2]
Phase 2 trial evaluating immunization of extensive-stage small cell lung cancer patients with chemotherapy with or without all-trans retinoi…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for radiation therapy in extensive-stage small cell lung cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC [Phase 3]
Phase 3 trial comparing irinotecan plus cisplatin (IP) versus etoposide plus cisplatin (EP) after EP/TRT for limited-stage small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Validation of the MiCK Assay
The MiCK Assay validation trial (NCT01770665) sponsored by Pierian Biosciences has been terminated, involving mesothelioma, small cell lung …
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: TF2- Small Cell Lung Cancer Radio Immunotherapy [Phase 1, Phase 2]
The clinical trial TF2 radioimmunotherapy for small cell lung cancer and non-small cell lung cancer has completed Phase 1 and Phase 2 studie…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: ZD6474 in Treating Patients With Small Cell Lung Cancer [Phase 2]
The Phase 2 trial of ZD6474 for small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 trial results update for alisertib in adults with advanced nonhematological malignancies, including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study of lepirudin in patients with recurrent or advanced small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 2]
An update on a Phase 2 trial evaluating chemotherapy plus radiation therapy for limited-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating cisplatin plus etoposide with or without paclitaxel in extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of chemotherapy and radiation therapy for patients with limited-stage small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone [Phase 3]
Phase 3 trial comparing ipilimumab plus etoposide and platinum to etoposide and platinum alone in extensive-disease small cell lung cancer h…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
This clinical trial update reports the results of a Phase 2 study of paclitaxel in patients with extensive-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating a combination chemotherapy regimen for recurrent or refractory small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial results evaluate the combination of topotecan, paclitaxel, and filgrastim in patients with previously untreated extensive-stag…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluating donepezil and vitamin E to prevent cognitive side effects from head radiation in patients with small cel…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer [Phase 2]
This Phase 2 study evaluated the combination of topotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer. Th…